Mon, Jan 26, 2015, 5:46 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Insmed Incorporated Message Board

  • gt_pharma gt_pharma Sep 11, 2013 8:44 AM Flag

    News: Insmed beefs up its Arikace intellectual property estate.

    INSM says it expects to receive a U.S. patent covering "an aerosolized composition of [the] novel, once-daily inhalation formulation comprising amikacin and liposomal delivery technology for the treatment of pulmonary infections."
    The company also says the European Patent Office intends to grant a patent covering Arikace's formulation "for the treatment of pulmonary infections in CF patients."

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
15.95+1.06(+7.12%)Jan 26 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.